LACTOSE (INDIA)
Back to Balance Sheet
|
LACTOSE (INDIA) Last 5 Year Contingent Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹7.80 Cr | ₹8.52 Cr | ₹6.59 Cr | ₹3.32 Cr | ₹3.16 Cr |
What is the latest Contingent Liabilities ratio of LACTOSE (INDIA) ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹7.80 Cr |
| Mar2024 | ₹8.52 Cr |
| Mar2023 | ₹6.59 Cr |
| Mar2022 | ₹3.32 Cr |
| Mar2021 | ₹3.16 Cr |
How is Contingent Liabilities of LACTOSE (INDIA) Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹7.80 Cr | -8.52 | |
| Mar2024 | ₹8.52 Cr | 29.32 | |
| Mar2023 | ₹6.59 Cr | 98.58 | |
| Mar2022 | ₹3.32 Cr | 4.93 | |
| Mar2021 | ₹3.16 Cr | - | |
Compare Contingent Liabilities of peers of LACTOSE (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LACTOSE (INDIA) | ₹138.4 Cr | 1.3% | 3.9% | 14.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹430,513.0 Cr | 0.6% | -2.8% | 6.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹176,570.0 Cr | 0.4% | 0.1% | 0.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹154,670.0 Cr | 3.4% | 4.3% | 42% | Stock Analytics | |
| CIPLA | ₹111,725.0 Cr | -1.3% | 7% | -7.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,424.0 Cr | -0.2% | 0.4% | -1.4% | Stock Analytics | |
LACTOSE (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LACTOSE (INDIA) | 1.3% |
3.9% |
14.9% |
| SENSEX | -0.7% |
-2.9% |
-8.9% |
You may also like the below Video Courses